Although other signaling elements such as the KIT oncogene, the tumor microenvironment (TME), and immune checkpoint inhibitors (ICIs) play relevant roles in melanoma biology, their further discussion is presented in the subsequent section—“Cutaneous Melanoma Treatment and Mechanisms of Action”—to maintain focus in the introduction on the central role of BRAF-targeted therapy. Here, BRAF is linked to melanoma.